Matsumoto N, Oishi A, Yoshino S, Masuo Y, Kubota Y, Ishida H, Shimada K, Kato Y, Fujita K*. ABCC4 polymorphism indirectly reduces systemic exposure to a capecitabine metabolite 5'-deoxy-5-fluorouridine in Japanese subjects. Br J Clin Pharmacol 91(11):3092-3103, 2025. 昭和医科大学の研究グループが中心の共同研究